Envista Holdings Corporation which can be found using ticker (NVST) have now 8 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price High/Low ranges between 47 and 41 calculating the average target price we see $44.50. Given that the stocks previous close was at $35.74 this would imply there is now a potential upside of 24.5%. The 50 day MA is $37.38 and the 200 day moving average is $36.39. The market capitalization for the company is 5.58B. The current share price for the company is: 34.11 USD
The potential market cap would be $6,952,502,538 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 28.19, revenue per share of 15.71 and a 3.29% return on assets.
Envista Holdings Corporation is a dental products company. The Company provides dental consumables, solutions, technology, and services. It has approximately 30 dental brands, including Nobel Biocare, Ormco and Kerr united. The Company operates through two segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems, and endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents and cements, and infection prevention products.
